This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ Preprints) and either DOI or URL of the article must be cited.
Cite this article
Armstrong-Hough M, Kishore S, Byakika S, Mutungi G, Nunez-Smith M, Schwartz J.2017. Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: a Poisson analysis using the Service Availability and Readiness Assessment. PeerJ Preprints5:e3197v1https://doi.org/10.7287/peerj.preprints.3197v1
Objective Although the WHO-developed Service Availability and Readiness Assessment (SARA) tool is a comprehensive and widely applied survey of health facility preparedness, SARA data have not previously been used to model predictors of readiness. We sought to demonstrate that SARA data can be used to model availability of essential medicines for treating non-communicable diseases (EM-NCD). Methods We fit a Poisson regression model using 2013 SARA data from 196 Ugandan health facilities. The outcome was total number of different EM-NCD available. Basic amenities, equipment, region, health facility type, managing authority, NCD diagnostic capacity, and range of HIV services were tested as predictor variables. Findings In multivariate models, we found significant associations between EM-NCD availability and region, managing authority, facility type, and range of HIV services. For-profit facilities’ EM-NCD counts were 98% higher than public facilities (p<.001). General hospitals and referral health centers had 98% (p=.004) and 105% (p=.002) higher counts compared to primary health centers. Facilities in the North and East had significantly lower counts than those in the capital region (p=0.015; p=0.003). Offering HIV carewas associated with 35% lower EM-NCD counts (p=0.006). Offering HIV counseling and testing was associated with 57% higher counts (p=0.048). Conclusion We identified multiple within-country disparities in availability of EM-NCD in Uganda. Our findings can be used to identify gaps and guide distribution of limited resources. While the primary purpose of SARA is to assess and monitor health services readiness, we show that it can also be an important resource for answering complex research and policy questions requiring multivariate analysis.
This is a preprint submission to PeerJ Preprints that is currently under external peer review.